Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
PLoS One. 2009 Nov 11;4(11):e7782. doi: 10.1371/journal.pone.0007782.
Sepsis likely contributes to the high burden of infectious disease morbidity and mortality in low income countries. Data regarding sepsis management in sub-Saharan Africa are limited. We conducted a prospective observational study reporting the management and outcomes of severely septic patients in two Ugandan hospitals. We describe their epidemiology, management, and clinical correlates for mortality.
METHODOLOGY/RESULTS: Three-hundred eighty-two patients fulfilled enrollment criteria for a severe sepsis syndrome. Vital signs, management and laboratory results were recorded. Outcomes measured included in-hospital and post-discharge mortality. Most patients were HIV-infected (320/377, 84.9%) with a median CD4+ T cell (CD4) count of 52 cells/mm(3) (IQR, 16-131 cells/mm(3)). Overall mortality was 43.0%, with 23.7% in-hospital mortality (90/380) and 22.3% post-discharge mortality (55/247). Significant predictors of in-hospital mortality included admission Glasgow Coma Scale and Karnofsky Performance Scale (KPS), tachypnea, leukocytosis and thrombocytopenia. Discharge KPS and early fluid resuscitation were significant predictors of post-discharge mortality. Among HIV-infected patients, CD4 count was a significant predictor of post-discharge mortality. Median volume of fluid resuscitation within the first 6 hours of presentation was 500 mLs (IQR 250-1000 mls). Fifty-two different empiric antibacterial regimens were used during the study. Bacteremic patients were more likely to die in hospital than non-bacteremic patients (OR 1.83, 95% CI = 1.01-3.33). Patients with Mycobacterium tuberculosis (MTB) bacteremia (25/249) had higher in-hospital mortality (OR 1.97, 95% CI = 1.19-327) and lower median CD4 counts (p = 0.001) than patients without MTB bacteremia.
Patients presenting with sepsis syndromes to two Ugandan hospitals had late stage HIV infection and high mortality. Bacteremia, especially from MTB, was associated with increased in-hospital mortality. Most clinical predictors of in-hospital mortality were easily measurable and can be used for triaging patients in resource-constrained settings. Procurement of low cost and high impact treatments like intravenous fluids and empiric antibiotics may help decrease sepsis-associated mortality in resource-constrained settings.
败血症可能是造成低收入国家传染病发病率和死亡率居高不下的主要原因。有关撒哈拉以南非洲败血症处理的数据十分有限。我们进行了一项前瞻性观察性研究,报告了乌干达两家医院严重败血症患者的处理和结局。我们描述了他们的流行病学、处理和与死亡率相关的临床特征。
方法/结果:382 名患者符合严重败血症综合征的纳入标准。记录了生命体征、处理和实验室结果。测量的结局包括院内和出院后死亡率。大多数患者感染了 HIV(320/377,84.9%),中位 CD4+T 细胞(CD4)计数为 52 个细胞/mm3(IQR,16-131 个细胞/mm3)。总死亡率为 43.0%,院内死亡率为 23.7%(90/380),出院后死亡率为 22.3%(55/247)。院内死亡率的显著预测因素包括入院时格拉斯哥昏迷量表和卡诺夫斯基表现量表(KPS)、呼吸急促、白细胞增多和血小板减少。出院时的 KPS 和早期液体复苏是出院后死亡率的显著预测因素。在 HIV 感染者中,CD4 计数是出院后死亡率的显著预测因素。在出现症状的最初 6 小时内,中位液体复苏量为 500 mL(IQR 250-1000 mls)。在研究期间使用了 52 种不同的经验性抗菌方案。菌血症患者的院内死亡率高于非菌血症患者(OR 1.83,95%CI=1.01-3.33)。感染结核分枝杆菌(MTB)的菌血症患者(25/249)的院内死亡率更高(OR 1.97,95%CI=1.19-327),CD4 计数中位数更低(p=0.001)。
两家乌干达医院就诊的败血症患者均为晚期 HIV 感染,死亡率较高。菌血症,尤其是 MTB 菌血症,与较高的院内死亡率相关。大多数与院内死亡率相关的临床预测因素均易于测量,可用于资源有限的环境下对患者进行分诊。采购低成本、高影响的治疗方法,如静脉补液和经验性抗生素,可能有助于降低资源有限环境下与败血症相关的死亡率。